Readings Flashcards
What was Papanicolas’ study?
Study on healthcare spending in the US compared to other high-incoming countries
What was Papanicolas’ data source?
OECD data on structural equipment, workforce, utilization, pharmaceuticals spending, access, and quality
What were Papanicolas’ key findings?
- healthcare use of social spending was not different between countries, however price of labor and good and administrative costs were
What are public and private policy implications of Papanicolas’ study?
- public: government control over pricing of drugs
- private: ACOs - promote care coordination to reduce admin costs and promote communication among providers while ensuring health standards
What are some limitations of the Papanicolas study?
- limited comparable data across health systems and countries
- data on prices across systems were lacking
- differences in practices
What is the Baicker study?
To develop a evidence-based health policy
What are the key suggestions of the Baicker paper?
- well specified healthcare policy
- distinguish between policies and goals
- requires evidence of the magnitude of the effects of the policy
What are some public and policy implications of the Baicker paper?
- will change how policies are listed as according to this paper they should be separate from goals
What are the limitations of the Baicker paper?
- nuances of evidence are lost when evidence is deployed in policy debates
- evidence cant guarantee the policy will work
What is the Arrow study?
The paper that evaluates the medical-care industry and its efficacy
What are the key findings of the Arrow paper?
- market failures are due to information asymmetry
- 1st Theorem: equilibrium is Pareto optimal
- 2nd Theorem: if there are no increasing returns to production, every optimal state is a competitive equilibrium that corresponds to initial allocation of goods
What is the Aron-Dine study?
The one that looked at RAND
What was the data source of Aron-Dine’s study?
RAND
What are the key findings of the Aron-Dine paper?
- more coverage -> higher utilization
- 3 threats to internal validity (non random assignment, differential participation across plans, differential reporting across plans)
What are the limitation of the Aron-Dine study?
- self selection - people opt out midway & report differently
- does not describe clinical outcomes